Page 298 - Read Online
P. 298

De Rosa et al. Mini-invasive Surg 2020;4:34  I  http://dx.doi.org/10.20517/2574-1225.2019.53                                  Page 11 of 12


                   2016;18:1154-61.
               32.  Ma B, Gao P, Song Y, Zhang C, Zhang C, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review
                   and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer
                   2016;16:380.
               33.  Deijen CL, Tsai A, Koedam TW, Veltcamp Helbach M, Sietses C, et al. Clinical outcomes and case volume effect of transanal total
                   mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 2016;20:811-24.
               34.  Xu W, Xu Z, Cheng H, Ying J, Cheng F, et al. Comparison of short-term clinical outcomes between transanal and laparoscopic total
                   mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis. Eur J Surg Oncol 2016;42:1841-50.
               35.  Koedam TWA, Veltcamp Helbach M, van de Ven PM, Kruyt PM, van Heek NT, et al. Transanal total mesorectal excision for rectal
                   cancer: evaluation of the learning curve. Tech Coloproctol 2018;22:279-87.
               36.  Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, et al.; MRC CLASICC trial group. Short-term endpoints of conventional versus
                   laparoscopicassisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet
                   2005;365:1718-26.
               37.  Veltcamp Helbach M, Deijen CL, Velthuis S, Bonjer HJ, Tuynman JB, et al. Transanal total mesorectal excision for rectal carcinoma:
                   short-term outcomes and experience after 80 cases. Surg Endosc 2016;30:464-70.
               38.  Simillis C, Hompes R, Penna M, Rasheed S, Tekkis PP. A systematic review of transanal total mesorectal excision: is this the future of
                   rectal cancer surgery? Colorectal Dis 2016;18:19-36.
               39.  Hua L, Wang C, Yao K, Zhang J, Chen J, et al. Is the incidence of postoperative anastomotic leakage different between laparoscopic
                   and open total mesorectal excision in patients with rectal cancer? A meta-analysis based on randomized controlled trials and controlled
                   clinical trials. J Can Res Ther 2014;10:272-5.
               40.  Penna M, Hompes R, Arnold S, Wynn G, Austin R, et al. Incidence and risk factors for anastomotic failure in 1594 patients treated by
                   transanal total mesorectal excision: results from the international TaTME registry. Ann Surg 2019;269:700-11.
               41.  Velthuis S, Veltcamp Helbach M, Tuynman JB, Le TN, Bonjer HJ, et al. Intra-abdominal bacterial contamination in TAMIS total
                   mesorectal excision for rectal carcinoma: a prospective study. Surg Endosc 2015;29:3319.
               42.  Wolthuis AM, Bislenghi G, Overstraeten ABV, D’Hoore A. Transanal total mesorectal excision: towards standardization of technique.
                   World J Gastroenterol 2015;21:12686-95.
               43.  Rouanet P, Mourregot A, Azar CC, Carrere S, Gutowski M, et al. Transanal endoscopic proctectomy: an innovative procedure for difficult
                   resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum 2013;56:408-15.
               44.  Ratcliffe F, Hogan AM, Hompes R. CO2 embolus: an important complication of TaTME surgery. Tech Coloproctol 2017;21:61-2.
               45.  Dickson EA, Penna M, Cunningham C, Ratcliffe FM, Chantler J, et al. Carbon dioxide embolism associated with total mesorectal
                   excision surgery. Dis Colon Rectum 2019;62:794-801.
               46.  Tuech JJ, Karoui M, Lelong B, De Chaisemartin C, Bridoux V, et al. A step toward NOTES total mesorectal excision for rectal cancer:
                   endoscopic transanal proctectomy. Ann Surg 2015;261:228-33.
               47.  De Rosa M, Rondelli F, Boni M, Ermili F, Bugiantella W, et al. Transanal total mesorectal excision (TaTME): single-centre early
                   experience in a selected population. Updates Surg 2019;71:157-63.
               48.  Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, et al. Macroscopic evaluation of rectal cancer resection specimen:
                   clinical significance of the pathologist in quality control. J Clin Oncol 2002;20:1729-34.
               49.  Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorectal excision results in low local recurrence rates in lymph node positive rectal
                   cancer. Dis Colon Rectum 2004;47:1145-9.
               50.  Rullier E, Denost Q, Vendrely V, Rullier A, Laurent C. Low rectal cancer: classification and standardization of surgery. Dis Colon Rectum
                   2013;56:560-7.
               51.  Velthuis S, Nieuwenhuis DH, Ruijter TE, Cuesta MA, Bonjer HJ, et al. Transanal versus traditional laparoscopic total mesorectal excision
                   for rectal carcinoma. Surg Endosc 2014;28:3494-9.
               52.  Hu D, Jin P, Hu L, Liu W, Zhang W, et al. The application of transanal total mesorectal excision for patients with middle and low rectal
                   cancer: a systematic review and metaanalysis. Medicine (Baltimore) 2018;97:e11410.
               53.  Roodbeen SX, Penna M, Arnold S, Wynn G, Warusavitarne J, et al. UK TaTME Registry Collaborative. A nationwide study on the
                   adoption and short-term outcomes of transanal total mesorectal excision in the UK. Minerva Chir 2019;74:279-88.
               54.  Lelong B, Meillat H, Zemmour C, Poizat F, Ewald J, et al. Short- and mid-term outcomes after endoscopic transanal or laparoscopic
                   transabdominal total mesorectal excision for low rectal cancer: a single institutional case-control study. J Am Coll Surg 2017;224:917-25.
               55.  Hol JC, van Oostendorp SE, Tuynman JB, Sietses C. Long-term oncological results after transanal total mesorectal excision for rectal
                   carcinoma. Tech Coloproctol 2019;23:903-11.
               56.  Larsen S, Pfeffer F, Kørner H. Norwegian moratorium on transanal total mesorectal excision. Br J Surg 2019;106:1120-1.
               57.  Pontallier A, Denost Q, Van Geluwe B, Adam JP, Celerier B, et al. Potential sexual function improvement by using transanal mesorectal
                   approach for laparoscopic low rectal cancer excision. Surg Endosc 2016;30:4924-33.
               58.  Kneist W, Wachter N, Paschold M, Kauff DW, Rink AD, et al. Midterm functional results of taTME with neuromapping for low rectal
                   cancer. Tech Coloproctol 2016;20:41-9.
               59.  Koedam TW, van Ramshorst GH, Deijen CL, Elfrink AK, Meijerink WJ, et al. Transanal total mesorectal excision (TaTME) for rectal
                   cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol 2017;21:25-33.
               60.  Rubinkiewicz M, Zarzycki P, Witowski J, Pisarska M, Gajewska N, et al. Functional outcomes after resections for low rectal tumors:
                   comparison of Transanal with laparoscopic Total Mesorectal excision. BMC Surg 2019;19:79.
   293   294   295   296   297   298   299   300   301   302   303